Announced Wed, 17 Jun · 12:03 IST
Exchange seeks clarification from Anthem Biosciences on Q4 FY26 results
Compliance
ANTHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.7%1-day move
₹764.00
prior close
₹767.80
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.3+0.3+0.3+4.7+3.1+0.4+1.2+0.6+1.3-1.5+1.8——
Up moveDown movePending
AI summary
NSE has asked Anthem Biosciences to clarify certain points on its financial results for the quarter ended 31 March 2026, under Regulation 33 of SEBI's listing rules. The company's response is awaited. Investors should watch for the company's reply to understand what the exchange has flagged.
Likely market impact
Pending clarification may cause short-term uncertainty; typically routine and resolved quickly once the company responds.